Structural & Functional Profile
While ML1167 remains largely uncharacterized functionally, its sequence analysis reveals conserved domains suggesting potential roles in bacterial metabolism or structural processes. Key physicochemical properties include:
Production Specifications
Commercial variants are available with standardized quality controls:
| Product Code | Host System | Tag | Purity | Price Range |
|---|---|---|---|---|
| RFL921MF | E. coli | His-tag | >90% (SDS-PAGE) | $1,200-$1,800 |
| CSB-CF346459MVN | E. coli | Variable tag* | >85% | $950-$1,400 |
*Tag type determined during production
Protein-Protein Interaction Studies: Compatible with yeast two-hybrid, co-IP, and pull-down assays
Antigen Production: Potential for antibody development against M. leprae epitopes
Structural Biology: Crystallization trials enabled by high purity grades
Documented Performance
In comparative studies with related mycobacterial proteins:
Species specificity restricts cross-organism studies
Functional data gaps require orthogonal validation methods
Priority investigations should address:
Functional Elucidation: ATPase activity screening
Host-Pathogen Interaction: Macrophage infection models
Diagnostic Potential: Serological response profiling in leprosy patients
KEGG: mle:ML1167
STRING: 272631.ML1167
Recombinant proteins often present expression challenges in mammalian systems due to multiple factors affecting the protein expression pathway. These "difficult to express" proteins face bottlenecks at different stages, making their production unpredictable and significantly impacting drug development processes. Some proteins may be limited in their post-translational processing after initial processing in the endoplasmic reticulum, while others may face issues during earlier stages of expression .
Research has shown that protein-specific limitations require tailored approaches, as no universal solution exists for overcoming poor recombinant protein production. Systematic screening of cellular processes along the protein expression pathway is necessary to identify the specific limiting step(s) for each target protein .
Computational analyses can help predict secretion difficulties for uncharacterized proteins. Research indicates that specific sequence features correlate with poor secretion potential. Particularly, proteins with increased abundance of positively-charged or hydrophobic surface regions are associated with poor or no protein secretion .
When planning expression studies for novel uncharacterized proteins like ML1167, screening amino acid sequences using computational approaches can provide valuable insights into potential secretion challenges before experimental work begins. This predictive approach saves resources by identifying problematic sequence features that may require protein engineering strategies.
While bacterial expression systems (such as E. coli) offer simplicity and high yields, mammalian expression systems have gained significant popularity for recombinant proteins requiring complex post-translational modifications. The choice depends largely on the protein's characteristics and intended application.
A systematic experimental design is crucial when working with uncharacterized proteins. Begin by defining your key variables - the independent variable (e.g., expression conditions) and dependent variable (e.g., protein yield, activity) . This foundation allows for the development of specific, testable hypotheses about the protein's characteristics.
For robust characterization of uncharacterized proteins, consider the following experimental design steps:
Generate a specific, testable hypothesis about the protein's function or properties
Design experimental treatments to manipulate independent variables (expression conditions, fusion tags, etc.)
Plan appropriate controls for each experimental condition
Determine methods to measure dependent variables (yield, activity, structure)
Control for extraneous variables that might influence results
Research has demonstrated that protein engineering approaches can successfully address expression limitations. For uncharacterized proteins limited by post-translational processing, targeted modifications to problematic sequence regions have proven effective .
One successful approach involves modifying positively-charged or hydrophobic surface regions identified through computational analysis. Engineering these problematic sequence features in model "difficult" recombinant targets has resulted in successful secretion where previous attempts failed . This targeted strategy addresses specific molecular mechanisms limiting expression rather than applying general optimization techniques.
Computational approaches provide valuable insights for uncharacterized proteins before experimental work begins. While the search results don't specifically address ML1167's structure prediction, general computational approaches for uncharacterized proteins include:
Sequence analysis to identify domains and motifs
Secondary structure prediction
Homology modeling when related structures exist
Molecular dynamics simulations to predict stability
Analysis of surface charge distribution and hydrophobicity, which has been shown to predict secretion potential
These computational tools can guide experimental design by identifying potential functional regions and expression challenges before laboratory work begins.
Systematic screening of cellular processes along the protein expression pathway is essential for identifying specific limiting factors. Research has demonstrated that a comprehensive approach examining multiple stages provides the most accurate assessment .
A methodological screening process should include:
Transcription efficiency analysis
Translation efficiency measurement
Post-translational modification assessment
Protein folding evaluation
Secretion pathway analysis
This systematic approach enables researchers to pinpoint the specific cellular processes restricting efficient protein production, which has been shown to vary in a protein-specific manner .
Optimization requires a structured experimental design approach with careful consideration of variables. Follow these methodological steps:
Define your variables clearly, distinguishing between independent variables (what you'll manipulate) and dependent variables (what you'll measure)
Develop a specific, testable hypothesis about optimal conditions
Design treatments that systematically test different expression conditions
Consider both between-subjects and within-subjects experimental designs depending on your research question
Implement controls for extraneous variables that might influence results
Select appropriate statistical methods for analyzing results
This methodological approach ensures scientifically valid optimization of expression conditions for novel proteins.
A comprehensive characterization requires multiple analytical approaches:
For structural analysis:
X-ray crystallography for atomic-level resolution
NMR spectroscopy for solution-state structure and dynamics
Cryo-EM for large complexes
Circular dichroism for secondary structure assessment
For functional analysis:
Activity assays based on predicted function
Protein-protein interaction studies (co-immunoprecipitation as demonstrated in case studies with other recombinant proteins)
Mass spectrometry for post-translational modification mapping
Systematic mutation analysis to identify functional residues
Case studies with other recombinant proteins have demonstrated the value of two-way co-immunoprecipitation experiments for confirming protein interactions and elucidating function . This approach could be applied to uncharacterized proteins like ML1167 to help determine their binding partners and potential cellular roles.
Poor yield is a common challenge with uncharacterized proteins and requires systematic troubleshooting. Research has identified several strategies to address this issue:
Identify the limiting step(s) through systematic screening of cellular processes
Apply protein engineering to problematic sequence regions, particularly those with positively-charged or hydrophobic surface areas
Optimize codon usage for the expression system
Explore fusion tags to improve solubility and expression
Consider alternative expression systems if mammalian systems prove challenging
The efficacy of these approaches depends on identifying the specific bottleneck limiting expression, as research has shown these limitations to be protein-specific .
Protein misfolding and aggregation often result from improper post-translational processing. Research indicates several approaches to address these challenges:
Modify culture conditions (temperature, pH) to slow protein synthesis and allow proper folding
Co-express molecular chaperones to assist folding
Use computational analysis to identify problematic sequence regions and apply targeted protein engineering
Consider fusion partners known to enhance solubility
Explore refolding protocols for proteins recovered from inclusion bodies
Research has demonstrated that engineering problematic sequence features identified through computational analysis can significantly improve proper folding and secretion of difficult recombinant targets .
Validation requires multiple complementary approaches to ensure confidence in characterization:
Structural validation:
Comparison of experimental structural data with computational predictions
Consistency across multiple structural analysis techniques
Stability assessment under physiological conditions
Functional validation:
Activity assays based on structural features and predicted function
Comparison with functionally related proteins
Interaction studies with predicted binding partners
Cellular localization consistent with proposed function
Case studies with other recombinant proteins have demonstrated the value of combined approaches. For example, researchers have used two-way co-immunoprecipitation to confirm protein interactions while simultaneously assessing downstream signaling effects to validate functional predictions .
While no specific emerging technologies for ML1167 research were mentioned in the search results, current advances in protein research include:
Machine learning approaches for improved prediction of protein properties and expression challenges
High-throughput screening methods for rapidly identifying optimal expression conditions
Advanced computational tools for more accurate structure prediction of novel proteins
CRISPR-based approaches for studying protein function in cellular contexts
These technologies provide researchers with new tools to address the challenges associated with recombinant uncharacterized proteins, potentially allowing more efficient characterization of proteins like ML1167.
Computational analysis has already demonstrated value in identifying problematic sequence features associated with poor protein secretion . Future developments in this area may include:
More sophisticated algorithms for predicting protein expression success based on sequence features
Improved models for predicting post-translational modifications
AI-driven approaches to design protein variants with improved expression characteristics
Integration of multiple computational tools to provide comprehensive expression prediction
Research has shown that increased abundance of positively-charged or hydrophobic surface regions correlates with poor secretion . Advancing these computational approaches will likely improve our ability to predict and address expression challenges before experimental work begins.